What is USANA Health Sciences's EV / EBITDA?

USANA Health Sciences (USNA) reported EV / EBITDA of 3.7× in Q4 2025.

What is the long-term trend for USANA Health Sciences's EV / EBITDA?

Over 3 years (2022 to 2025), USANA Health Sciences's EV / EBITDA has grown at a -19.6% compound annual growth rate (CAGR), from 7× to 3.7×.

What does EV / EBITDA mean?

Enterprise value (market cap plus total debt minus cash) at the quarter end divided by trailing-twelve-month EBITDA. A capital-structure-neutral valuation multiple.

USANA Health Sciences USNA EV / EBITDA

EV / EBITDA at other companies

Nature's Sunshine ProductsNATR

8.5×+4.1×

HerbalifeHLF

5.3×0.0×

BellRing BrandsBRBR

9.8×-13.3×

United Natural FoodsUNFI

16.7×+3.4×

US FoodsUSFD

15.3×+3.0×

Universal CorporationUVV

9.3×+1.6×

Other financials

Income statement

See full

Revenue$250.2M+0.3%

Gross profit$190.8M-3.2%

Operating income$13.9M-11.5%

Net income$7.5M-20.1%

EPS (diluted)$0.41-16.3%

Balance sheet

See full

Cash & equivalents$165.7M-9.2%

Total debt$18.0M+10.8%

Total equity$543.6M+2.6%

Total assets$739.0M-1.0%

Cash flow

See full

Operating cash flow$9.8M-37.0%

CapEx$2.6M-5.6%

Free cash flow$7.1M-43.9%

Valuation

See full

Market cap$363.35M-36.1%

P/E18.1×+7.8×

P/S0.4×-0.3×

Profitability

See full

Gross margin77.6%-3.0pp

Operating margin3.8%-2.7pp

Net margin1.9%-4.4pp

FCF margin5.7%-1.1pp

Returns & leverage

See full

Return on equity3.2%-7.6pp

Debt / equity0×0.0×

Current ratio2.5×+0.5×

Where this comes from

Calculated from USANA Health Sciences’s reported figures.

enterprise value/ebitda=3.7×

Based on the most recent quarter.

The official record: USANA Health Sciences’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →

Ask your AI about USANA Health Sciences's ev / ebitda.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is USANA Health Sciences's EV / EBITDA?: USANA Health Sciences (USNA) reported EV / EBITDA of 3.7× in Q4 2025.
What is the long-term trend for USANA Health Sciences's EV / EBITDA?: Over 3 years (2022 to 2025), USANA Health Sciences's EV / EBITDA has grown at a -19.6% compound annual growth rate (CAGR), from 7× to 3.7×.
What does EV / EBITDA mean?: Enterprise value (market cap plus total debt minus cash) at the quarter end divided by trailing-twelve-month EBITDA. A capital-structure-neutral valuation multiple.